scholarly journals MOLECULAR IDENTIFICATION OF SARCOPTES SCABIEI VAR. CUNICULI FROM SURABAYA AND MALANG REGIONS OF EAST JAVA

2017 ◽  
Vol 6 (6) ◽  
pp. 150 ◽  
Author(s):  
Kurnia Desiandura ◽  
Nunuk Dyah Retno Lastuti ◽  
Lucia Tri Suwanti ◽  
Didik Handijatno
Keyword(s):  
Molecular Identification ◽  
Animal Health ◽  
Sarcoptes Scabiei ◽  
Molecular Diagnostic ◽  
Cox1 Gene ◽  
Morphological Studies ◽  
Diagnostic Center ◽  
Amplicon Size ◽  
Domestic Rabbits ◽  
Global Threat

Scabies is a zoonotic skin disease caused by Sarcoptes scabiei mites. As an emerging/re-emerging parasitic disease, scabies represents a significant global threat to both human and animal health. Numerous cases of scabies in Indonesia have been reported, which support research on the prevalence of S. scabiei. However, most such studies have involved conventional morphological studies, with limited molecular diagnostic studies. The purpose of the present study was the genetic characterization of S. scabiei var. cuniculi in domestic rabbits to generate baseline genotypic data. S. scabiei var. cuniculi was isolated and identified from scabies-infected rabbits from the Surabaya and Malang regions of East Java. Molecular identification was performed using Polymerase Chain Reaction (PCR) using specific primers targeting the COX1 gene. We performed COX1 PCR using rabbit isolates of S. scabiei from Indonesia. To the best of our knowledge, no such study had been reported previously. This study was performed in the Laboratory of Veterinary Parasitology, Faculty of Veterinary Medicine and the Tropical Disease Diagnostic Center Laboratory, Universitas Airlangga. The results with agarose gel electrophoresis revealed a 289 bp PCR product amplified from the DNA of S. scabiei isolates from both Surabaya and Malang in accordance with the expected COX1 amplicon size, that indicated a single band 289 bp in length, demonstrating specific detection of S. scabiei var. cuniculi from Surabaya and Malang using COX1 primers. The results were consistent with the calculated amplicon size based on primer positions within the COX1 locus, with the forward primer spanning nucleotides 61–94, and the reverse primer spanning nucleotides 331–350 ( 350 − 61 = 289 bp).  PCR genotyping of the isolates yielded an identical nucleotide length of 289 bp. Further studies are required to sequence the amplified fragments for homology assessment.

scholarly journals Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance

Antibiotics ◽  
2020 ◽  
Vol 10 (1) ◽  
pp. 3
Author(s):  
Cristina Uruén ◽  
Gema Chopo-Escuin ◽  
Jan Tommassen ◽  
Raúl C. Mainar-Jaime ◽  
Jesús Arenas
Keyword(s):  
Close Contact ◽  
Animal Health ◽  
Deep Understanding ◽  
Growth Conditions ◽  
Multidrug Resistant ◽  
Extracellular Dna ◽  
Resistant Bacteria ◽  
Resistance To Antibiotics ◽  
Global Threat ◽  
Biofilm Development

Multidrug resistant bacteria are a global threat for human and animal health. However, they are only part of the problem of antibiotic failure. Another bacterial strategy that contributes to their capacity to withstand antimicrobials is the formation of biofilms. Biofilms are associations of microorganisms embedded a self-produced extracellular matrix. They create particular environments that confer bacterial tolerance and resistance to antibiotics by different mechanisms that depend upon factors such as biofilm composition, architecture, the stage of biofilm development, and growth conditions. The biofilm structure hinders the penetration of antibiotics and may prevent the accumulation of bactericidal concentrations throughout the entire biofilm. In addition, gradients of dispersion of nutrients and oxygen within the biofilm generate different metabolic states of individual cells and favor the development of antibiotic tolerance and bacterial persistence. Furthermore, antimicrobial resistance may develop within biofilms through a variety of mechanisms. The expression of efflux pumps may be induced in various parts of the biofilm and the mutation frequency is induced, while the presence of extracellular DNA and the close contact between cells favor horizontal gene transfer. A deep understanding of the mechanisms by which biofilms cause tolerance/resistance to antibiotics helps to develop novel strategies to fight these infections.

scholarly journals Molecular Diagnostic of Ochratoxin A with Specific Aptamers in Corn and Groundnut via Fabrication of A Microfluidic Device

2021 ◽  
Author(s):  
Deepshikha Shahdeo ◽  
Azmat Ali Khan ◽  
Amer M Alanazi ◽  
Yun Suk Huh ◽  
Shruti Shukla ◽  
...  
Keyword(s):  
Ochratoxin A ◽  
Limit Of Detection ◽  
Colorimetric Assay ◽  
Animal Health ◽  
Colorimetric Detection ◽  
Molecular Diagnostic ◽  
Detection Range ◽  
Vis Spectroscopy ◽  
Wide Range ◽  
Analytical Device

Abstract Ochratoxin A (OTA) is one of the predominant mycotoxins that contaminate a wide range of food commodities. In the present study, a 36-mer aptamer was used as a molecular recognition element coupled with gold nanoparticles (AuNPs) for colorimetric detection of OTA in a microfluidic paper-based analytical device (µPADs). The µPADs consisted of three zones: control, detection, and sample, interconnected by channels. The biophysical characterizations of aptamer conjugated AuNPs were done by UV-vis spectroscopy (UV-vis), dynamic Light Scattering (DLS), and transmission electron microscopy (TEM). The developed colorimetric assay for OTA showed a limit of detection of 242, 545, and 95.69 ng/mL in water, corn, and groundnut, respectively. The HPLC detection method achieved acceptable coefficient in standard curves (r2 = 0.9995), better detection range, and recovery rates in spiked corn and groundnut samples as 43.61 ± 2.18% to 87.10 ± 1.82% and 42.01 ± 1.31% to 86.03 ± 2.64% after multiple sample extractions and cleanup steps. However, the developed µPADs analytical device had the potent ability to rapidly detect OTA without any extraction pre-requirement, derivatization, and cleanup steps, thus illustrating its feasibility in the animal health sector, agricultural, and food industries.

Recent advances in the laboratory diagnosis of peste des petits ruminants

2021 ◽  
Vol 77 (05) ◽  
pp. 226-231
Author(s):  
WIESŁAW NIEDBALSKI ◽  
ANDRZEJ FITZNER ◽  
KRZYSZTOF BULENGER ◽  
ANDRZEJ KĘSY
Keyword(s):  
Reverse Transcription ◽  
Animal Health ◽  
Clinical Signs ◽  
Small Ruminants ◽  
Clinical Diagnostics ◽  
Molecular Diagnostic ◽  
Molecular Diagnostic Techniques ◽  
Peste Des Petits Ruminants ◽  
Rt Pcr ◽  
Agar Gel

Peste des petits ruminants (PPR) is a highly contagious and economically important, viral disease of small ruminants caused by the peste des petits ruminants virus (PPRV), which belongs to the genus Morbilivirus in the family Paramyxoviridae. PPR control is achieved mostly through vaccination and/or slaughter of susceptible animals coupled with clinical or laboratory-based diagnosis. Since clinical signs of PPR are not disease-specific and clinical diagnostics is not reliable, it should be confirmed by laboratory testing. Laboratory confirmation of clinical suspicions is made by detection of PPRV in blood, swabs or post-mortem tissues through classical virus isolation (VI), agar gel immunodiffusion (AGID)/agar gel precipitation test (AGPT), counter-immunoelectrophoresis (CIE), immunoperoxidase test (IPT) or enzyme-linked immunosorbent (ELISA) assays. However, these conventional methods have been superseded by more rapid, sensitive and accurate molecular diagnostic techniques based on the amplification of parts of either nucleocapsid (N) or fusion (F) protein gene, such as RT-PCR, real-time RT-PCR, reverse transcription loop-mediated isothermal amplification (RT-LAMP), reverse transcription recombinase polymerase amplification (RT-RPA) and Oxford nanopore MinION technology. Although these molecular diagnostic assays are accurate, rapid and sensitive, they have to be performed in laboratory settings, and samples must be transported under appropriate conditions from the field to the laboratory, which can delay the confirmation of PPRV infection. The recently developed immunochromatographic lateral flow device (IC-LFD) assay can be used in the field (“pen-side”) without the need for expensive equipment, so a well-established laboratory is not required. The control and eventual eradication of PPR is now one of the top priorities for the Food and Agriculture Organization (FAO) and the World Organization for Animal Health (OIE). In 2015, the international community agreed on a global strategy for PPR eradication, setting 2030 as a target date for elimination of the disease

scholarly journals Effect of delayed plasma centrifugation on equine adrenocorticotropic hormone concentration

2019 ◽  
Vol 31 (4) ◽  
pp. 585-587 ◽  
Author(s):  
Kayla N. Shepard ◽  
John C. Haffner ◽  
Dwana L. Neal ◽  
Steven T. Grubbs ◽  
Greg L. Pearce
Keyword(s):  
Whole Blood ◽  
Adrenocorticotropic Hormone ◽  
Animal Health ◽  
Pars Intermedia ◽  
Plasma Acth ◽  
Cornell University ◽  
Diagnostic Center ◽  
Acth Concentration ◽  
Baseline Values ◽  
The Mean

Plasma adrenocorticotropic hormone (ACTH) concentration is used in the diagnosis of pituitary pars intermedia dysfunction (PPID) in horses. We enrolled 10 horses, 5 PPID-positive and 5 PPID-negative, in our study, September 20–22, 2016. On day 0, 5 mL of whole blood was collected into each of 6 EDTA tubes and immediately placed in a refrigerator at 7°C. One tube was centrifuged within 15 min of collection, followed by centrifugation of one tube from each horse at 4, 8, 12, 24, and 36 h following collection. At each time, centrifuged plasma was pipetted into 1.5-mL polypropylene tubes and stored at −80°C. None of the plasma samples were turbid, hemolyzed, or icteric. Plasma was shipped frozen with cold packs overnight to the Animal Health Diagnostic Center of Cornell University (Ithaca, NY) for analysis. The percent change from baseline (PCFB) was reported to standardize the data given that baseline values differed. The mean PCFB was 2.8 (95% confidence interval: –2.9%, 7.0%). Neither refrigeration of whole blood for up to 36 h prior to centrifugation nor freezing affected plasma ACTH concentrations significantly.

Determination of the ability of a novel, long-acting subcutaneous GnRH antagonist, VERU-100, to castrate without a testosterone surge in a rat model.

2020 ◽  
Vol 38 (6_suppl) ◽  
pp. 128-128
Author(s):  
Robert H. Getzenberg ◽  
Jui-Chen Lin ◽  
Andrew Cerro ◽  
Christopher A. Rhodes ◽  
Mitchell S. Steiner
Keyword(s):  
Prostate Cancer ◽  
Advanced Prostate Cancer ◽  
Gnrh Antagonist ◽  
Animal Health ◽  
High Volume ◽  
Dose Finding ◽  
Loading Dose ◽  
Sprague Dawley ◽  
Gnrh Antagonists ◽  
Diagnostic Center

128 Background: Androgen deprivation therapy (ADT) is the mainstay for the treatment of advanced prostate cancer. LHRH agonists are frequently used for ADT but these agents often result in initial surges in testosterone (T) levels. Although they do not result in initial T surges, current injectable GnRH antagonists are short term (1 month) subcutaneous (sc) depots that require a high volume loading dose followed by monthly maintenance dosing. VERU-100 is a novel GnRH decapeptide antagonist for long term suppression of T to castrate levels and is administered as a low volume sc injection without the requirement of a loading dose. Eight distinct formulations were evaluated in rats in order to select the best formulation, VERU-100. Methods: Male Sprague Dawley rats (n=3 per group) were injected sc through a 21G needle, with approximately 200 μl of each formulation at a dose level of 20 mg/kg. Eight groups consisting of the distinct test formulations were evaluated. Blood samples were drawn at weekly intervals until week 4 and then bi-weekly for pharmacokinetic (PK) (Integrated Analytical Solutions) and testosterone (T) level determinations (Cornell University Animal Health Diagnostic Center). Results: Within approximately 24 hours after administration of the GHRH antagonist formulations, testosterone levels in the rats went from a mean of 7.36 ng/ml to undetectable. The T levels resulting from a single injection of the lead formulation in these studies, VH-030-002, remained undetectable for greater than 26 weeks (6 months) as did the other formulations tested. The corresponding PK analysis demonstrated that the GnRH antagonist levels were detectable for greater than 26 weeks and remained above 1 ng/ml for almost all of the study points. The T levels correlated to the exposure from the formulations, and PKPD was as consistent for GnRH antagonists. Conclusions: VERU-100 is a novel GnRH antagonist formulation that in this rodent study, with a low injection volume, resulted in undetectable T for at least six months. No surge of T is observed after administration. An IND submission is anticipated in early 2020 for the dose finding Phase 2 trial in men with advanced prostate cancer.

scholarly journals Mange skin diseases in dogs and cats in Jataí, Brazil: A retrospective study with notes on zoonotic aspects

2021 ◽  
Vol 10 (1) ◽  
pp. e10610111417
Author(s):  
Thâmara Rossi Martins da Silva ◽  
Micael Siegert Schimmunech ◽  
Priscilla Juliane Kirchhoff Pott ◽  
Ana Vitória Alves-Sobrinho ◽  
Priscila Gomes de Oliveira ◽  
...  
Keyword(s):  
Skin Diseases ◽  
Animal Health ◽  
Skin Lesions ◽  
Sarcoptes Scabiei ◽  
Zoonotic Potential ◽  
Mite Control ◽  
Health Studies ◽  
Notoedres Cati ◽  
Veterinary Hospital ◽  
Otodectes Cynotis

The parasitic skin diseases, specifically mange diseases, are highly relevant in the animal health studies, due to a significant number of cases in the veterinary routine, beyond the importance in public health, due to zoonotic potential. Therefore, this study aimed report the occurrence of mange skin diseases with notes in the zoonotic potential from Jataí, Goiás, by an retrospective survey of mange cases diagnosed in dogs and cats treated at the Veterinary Hospital of the Federal University of Jataí. A total of 612 reports of parasitological tests, comprising cerumen swabs and skin scraping, were analyzed from January 2016 to December 2019. The most common causative mite in dogs was Demodex canis (10.94%), followed by Otodectes cynotis (2.92%), and Sarcoptes scabiei (2.54%). The most common causative mite in cats was Notoedres cati (20%), followed by O. cynotis (10%). These skin diseases are characterized as being highly contagious; therefore, these can be easily transmitted among animals and even humans. In addition, intense itching and skin lesions lead to discomfort, consequently causing stress to the animals. Thus, mite control as well as prompt diagnosis and treatment are relevant to manage these skin diseases and ensure animal welfare.

scholarly journals Survey of protozoan vector-borne diseases in dogs from Atlantic Rainforest fragment around Billings Dam, São Paulo, Brazil

2020 ◽  
Vol 50 (9) ◽  
Author(s):  
Roberta Carvalho de Freitas e Azevedo ◽  
Giovanna Stefani Nosberto Castelli ◽  
Ryan Emiliano da Silva ◽  
Jaciara de Oliveira Jorge Costa ◽  
Renata Tonhosolo ◽  
...  
Keyword(s):  
Animal Health ◽  
Companion Animals ◽  
Sao Paulo ◽  
Control Measures ◽  
Molecular Diagnostic ◽  
São Paulo ◽  
Vector Borne Diseases ◽  
Babesia Vogeli ◽  
Vector Borne ◽  
The Impact

ABSTRACT: Vector-borne diseases are currently one of the biggest public health concerns worldwide. Dogs, being the closest companion animals to humans, are considered the main reservoir of some of these diseases in the urban environment. Therefore, the study of the disease behavior in dogs can help to understand the disease affecting human health. Serological and molecular diagnoses of Babesia vogeli, Rangelia vitalli, Leishmania infantum, and other trypanosomatids, were performed by immunochromatographic and PCR assays, respectively, on dogs in a dog shelter located in an Atlantic Forest fragment near the Billings Dam, São Bernardo do Campo, São Paulo-Brazil. Our molecular diagnostic results showed a high prevalence of Babesia vogeli, at 20.9% (17/81). No other protozoan was detected in any of the tests. Determining the prevalence of major vector-borne diseases is essential to establish preventive and control measures for zoonotic diseases in animals kept in shelters, in order to minimize the impact of vector-borne diseases on animal health.

scholarly journals Caroli’s-type ductal plate malformation and a portosystemic shunt in a 4-month-old kitten

2018 ◽  
Vol 4 (2) ◽  
pp. 205511691881232
Author(s):  
Madeleine L Roberts ◽  
Stacy Rine ◽  
Amy Lam
Keyword(s):  
Liver Biopsy ◽  
Animal Health ◽  
Portosystemic Shunt ◽  
Neurological Deficits ◽  
Surgical Biopsy ◽  
Pathology Laboratory ◽  
Ductal Plate ◽  
Diagnostic Center ◽  
History Of ◽  
Ductal Plate Malformation

Case summary A 4-month-old neutered male Russian Blue kitten had a 4 week history of hypersalivation and failure to thrive. In addition, there was a 2 week history of soft tissue swelling on the ventral abdomen, which had failed to improve with antimicrobial therapy. There were no significant physical examination or neurological deficits on examination; however, the cat had a quiet demeanour for its age. Postprandial bile acids were increased (32 µmol/l; reference interval <25 µmol/l). An abdominal CT scan revealed changes consistent with an extrahepatic portosystemic shunt and inflammation of fat of the ventral abdominal body wall. Surgical biopsy and culture of the subcutaneous swelling identified non-infectious steatitis. Ten weeks following initial presentation, surgical exploration, liver biopsy and ligation of the portosystemic shunt were performed. Liver biopsy was submitted to the Anatomical Pathology Laboratory of Cornell University Animal Health Diagnostic Center, New York, USA. Histopathology revealed a ductal plate malformation (Caroli’s type), as well as changes consistent with a portosystemic shunt. Relevance and novel information Ductal plate malformations are rarely described in the veterinary literature. To our knowledge this is the first reported case of Caroli’s-type malformation in a cat. There are no biochemical changes that allow for differentiation of ductal plate malformations from other hepatopathies. Liver biopsy is required for a definitive diagnosis.

Sign in / Sign up

Export Citation Format

Share Document